KINETIC CONCEPTS (NYSE:KCI)

“I am very pleased to see the progress of KCI’s business in light of continued economic and competitive pressures,” said Catherine Burzik, President and Chief Executive Officer of KCI. “KCI continues to meet its goals in terms of innovation, global market expansion and operational efficiency. We recently introduced our highly innovative open abdominal wound system, AbThera, to operating room surgeons in the U.S. and Europe and we are on track with our plans for the launch of V.A.C. Therapy in Japan. We look forward to the second half of the year with confidence.”   KCI has reaffirmed its previously stated guidance.

Source: Business Wire (July 21, 2009)

GuidanceReport: 

 EPS Figures exclude one time gains and charges (Non-GAAP).

These estimates appear to be above analyst estimates by about 11% .

The Company’s practice is to provide guidance on a full-year basis. However, the Company has historically experienced a seasonal fluctuation in sequential revenue between the fourth quarter and first quarter of each year. As a result of this historical experience, the Company currently expects that revenue in the first quarter of 2009 will reflect a modest decline from the fourth quarter of 2008.

Source: Business Wire (January 27, 2009)